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Abstract
Lymphoblastoid cell lines (LCL) are being actively and extensively used to examine the expression of specific genes and
genome-wide expression profiles, including allele specific expression assays. However, it has recently been shown that
approximately 10% of human genes exhibit random patterns of monoallelic expression within single clones of LCLs.
Consequently allelic imbalance studies could be significantly compromised if bulk populations of donor cells are clonal, or
near clonal. Here, using X chromosome inactivation as a readout, we confirm and quantify widespread near monoclonality
in two independent sets of cell lines. Consequently, we recommend where possible the use of bulk, non cell line, ex vivo
cells for allele specific expression assays.
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Introduction
Lymphoblastoid cell lines (LCL), which have been immortalised
by infection with Epstein Barr Virus (EBV), are being actively and
extensively used to examine the expression of specific genes and
genome-wide expression profiles [1,2,3,4]. Researchers are linking
and associating single nucleotide polymorphisms (SNPs) with
inherited, expression quantitative trait loci (eQTL) using tens to
hundreds of LCLs. A complementary approach is the analysis of
allelic imbalance of gene expression owing to unequal transcription
(or splicing) from the two alleles or haplotypes using RNA samples
from individuals who are heterozygous at the eQTL SNP. Allelic
imbalance approaches have the advantage of assessing expression
within an individual rather than across subjects thereby avoiding
several sources of error and variation. However, it has recently been
shown that approximately 10% of human genes exhibit random
patterns of monoallelic expression within single clones of LCLs [5].
Consequently, in a clonal or near clonal LCL, gene expression
measurements may not be representative of the in vivo cell population
and allelic imbalance studies could be significantly compromised.
Nevertheless, although it is published [6] that some widely used
LCLs are pauciclonal or even monoclonal, it is still not fully
appreciated that bulk LCL cultures can be highly restricted in the
number of constituent clones, as evidenced by the exclusive use of
cell lines in most recent studies [1,2,3,4]. Here, using X
chromosome inactivation (XCI) as a measure of the degree of
clonality, we confirm and quantify widespread near monoclonality
in two independent sets of 466 and 708 cell lines. Our results
suggest that the loss of diversity occurs in the early stages of the
LCL preparation and, therefore, affects equally freshly prepared,
as well as established cell lines such as the HapMap LCLs [6].
Results
We measured XCI using a standard assay in all our samples [7]
and observed large differences between cell lines (T1D and British
1958 Birth Cohort [8]) and controls (healthy Turkish women) for
which DNA was isolated directly from peripheral blood (Figure 1).
This high skew in XCI is associated with clonality in LCLs: when a
LCL reaches near clonality, the skew in XCI tends to increase
until reaching 100% [9]. We used these differences between both
sets of healthy samples (British 1958 Birth Cohort cell lines and
Turkish controls) to quantify the reduction in diversity in the
transformed cell lines.
Our statistical model assumes two potential outcomes for a cell
line transformation. In the first case, with probability 1-f, the
transformed cell line accurately reflects the level of skewing from
the initial cell population. In the second case, with probability f,
the transformation process subsamples n cells from the initial pool
and the final population consists of an equal mixture of the
descendants of these n cells. Note that we do not assume that the
final cell line is formed from only the descendants of n cells, but
that the combination of the initial LCL transformation with the
variation in growth rate among cell lineages leads to a bias in
measurement equivalent to a bottleneck of n cells which then grow
equally. We present this estimate as an informative summary
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statistic of the effect of near clonality on the expression
measurement. We assume that the number n is distributed as a
Poisson random variable with mean m and we are interested in the
joint estimation of both parameters f and m.
We first computed the profile log-likelihood for the parameter f
denoting the fraction of cell lines that underwent a bottleneck (see
Figure 2, Data S1 and Code S1). We found that the maximum
likelihood estimate for f varies with the accuracy of the XCI assay,
this estimate going down when the average error increases (see
Figure 2). The precision of the XCI assay is not known exactly but
the average error is expected to lie within 0.03–0.05 [10].
Assuming a XCI assay average error of 0.05, we estimated that
pauciclonality affects 60% of the LCLs. When the XCI assay error
varied between 0.03 and 0.05, the average number of clones in
pauciclonal LCLs was estimated between 4 and 5.
However, while previous estimates suggest that an average error
of 0.1 for the XCI is an overestimation, this scenario appeared to fit
the data better (2DlogL=6.6, p=0.01 compared to the best scenario
assuming an average measurement error of 0.05). Moreover,
assuming an average measurement error of 0.1, we cannot reject
the assumption that the bottleneck always involves a single clone. It
indicates that a likely scenario is a situation where the XCI in most
LCLs reflect the XCI in whole blood but approximately 22% of the
LCLs do not grow properly and become monoclonal.
These estimates rely on the assumption that the pattern of XCI is
similar between the British population and the Turkish control
samples. Indeed, the pattern of XCI is relatively constant across
populations (see [10,11,12,13,14,15] and Table 1) and ethnic
differences are unlikely to explain the strong differences we observe.
Using information about the cell line preparation for the T1D
samples, we examined what variables explained the variability in
XCI. Volume of blood drawn, date of bleed, age of blood at
first freeze (before transformation) and number of re-growths
(defined as successive cell line growths from a frozen sample)
showed no significant correlation with XCI (P.0.05). However,
the time required for first growth (defined as the time from
transformation until the culture volume reaches 100 ml) is
positively correlated with skewed XCI (correlation coefficient
r=0.19, P=761026). Figure 3 shows how extreme XCI
(.90%) correlates with this covariate. These data suggest that
loss of diversity occurs during or shortly after transformation: in
the case of slow initial growth, stochastic variability would have
an increased effect because of the small number of EBV infected
cells. It is likely that subsequent events, including re-growths,
have a limited impact because of a higher cell count when they
occur. We also note that even cell lines with the shortest time
for first growth (less than 22 days) are still significantly more
skewed than our control samples (DNA obtained from whole
blood), indicating that a robust early growth does not guarantee
absence of clonality.
We then investigated whether our statistical model could
explain the pattern of XCI observed in the data. We simulated
data using our best fitting parameters and compared the results
with XCI in both sets of cell lines (Figure 4). This comparison
provided mixed results. While our model properly explained the
excess of samples with extreme skewing (95–100% XCI) observed
in cell line samples, we could not explain the excess of cell lines
samples with XCI between 50 and 55%. A potential explanation is
that subtle differences occurred in the XCI assay. Because the XCI
assay is primarily designed to identify highly skewed individuals, it
is plausible that it is not robust to small experimental differences
when trying to distinguish XCI in the 50–70% range.
5055 5560 6065 6570 7075 7580 8085 8590 9095 95100
Measured skew in X inactivation
Pe
rc
en
ta
ge
s
0
5
10
15
20
25
30
35
Distribution of XCI
1958 BBC transformed cell lines
T1D transformed cell lines
Turkish samplesperipheral blood
Figure 1. Distribution of XCI in the British 1958 Birth Cohort samples, JDRF/WT T1D cases collection (both with DNA extracted from
transformed cells lines) and the control Turkish population (DNA extracted from peripheral blood).
doi:10.1371/journal.pone.0002966.g001
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Figure 2. Likelihood curve for the fraction of cells f that underwent a bottleneck. We considered three values for the standard error in the
measurement of the skew in X inactivation (standard deviation of 0.03, 0.05 and 0.1). The horizontal line indicates the 95% confidence interval.
doi:10.1371/journal.pone.0002966.g002
Table 1. Levels of X chromosome inactivation skewing in different groups of healthy and diseased individuals.
Population gtotal ginformative .90% 80–89% 50–79% Source of DNA
T1D cases-Great Britain
T1D-#40days transformation{ 367 66 (18) 39 (10.4) 262 (71.6) Cell line
T1D-.40days transformation{ 180 70 (38.9) 16 (8.9) 94 (52.2) Cell line
T1D-all{ 708 547 136 (24.8) 55 (10.1) 356 (65.1) Cell line
Healthy controls
Great Britain
British 1958 Birth Cohort{ 466 311 65 (20.9) 32 (10.3) 214 (68.8) Cell line
Turkey
Adult [11] 160 124 3 (2.41) 7 (5.6) 114 (91.9) Peripheral blood
Children{ 92 72 2 (2.8) 6 (8.3) 64 (88.9) Peripheral blood
Newborn{ 91 52 2 (3.8) 2 (3.8) 48 (92.3) Peripheral blood
North America
Adult/Mix-US [10] - 415 22 (5.3) 59 (14.2) 334 (80.5) Peripheral blood
Adult/Unknown-US [14] 114 100 1 (1.0) 7 (7.0) 92 (92.0) Peripheral blood
Newborn-USA [10] - 590 4 (0.7) 29 (4.9) 557 (94.4) Peripheral blood
Adult/Unknown-Canada [12] 109 97 8 (8.2) 15 (15.0) 74 (76.3) Peripheral blood
Other
Adult/Caucasian-Italy [13] - 164 10 (6.1) 22 (13.4) 132 (80.5) Peripheral blood
Adult/Caucasian-Denmark [15] - 96 1 (1.0) 10 (10.0) 85 (89.0) Peripheral blood
Adult/Caucasian-Tunisia{ 97 46 4 (8.7) 5 (10.9) 37 (80.4) Peripheral blood
The first number represents the number of samples in each of the three categories (XCI.90%; between 80–89% and 50–79%). The number in parenthesis is the
percentage this category represents.
{Unpublished.
doi:10.1371/journal.pone.0002966.t001
LCL Clonality
PLoS ONE | www.plosone.org 3 August 2008 | Volume 3 | Issue 8 | e2966
0.
0
0.
1
0.
2
0.
3
0.
4
0.
5
0.
6
Time required for first growth and XCI in T1D samples
Co
nf
id
en
ce
 in
te
rv
al
 fo
r t
he
 p
ro
ba
bi
lity
 o
f X
CI
 >
 9
0%
Time required for first growth (in days)
PB: DNA from Peripheral blood, Turkish samples
 
 
 
 
 
 
 
 
 
 
 
PB 18 
22
22 
24
24 
27
27 
29
29 
31
31 
34
34 
41
41 
51
51 
83
>83
Figure 3. Confidence intervals for the probability of XCI.90% as a function of the time required for first growth (ie. between
transformation and until the culture volume reaches 100 ml).
doi:10.1371/journal.pone.0002966.g003
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Figure 4. Simulation study comparing the XCI between our best fitting scenario and both sets of cell line (1958 British Birth Cohort
and T1D samples).
doi:10.1371/journal.pone.0002966.g004
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Discussion
Based on our XCI assay, we estimate that pauciclonality affects
approximately 20% of the LCLs in our study. While XCI is a
useful readout for pauciclonality, additional readouts, such as the
number of tandem repeat sequences in the EBV genome [16] or
the structure of the rearranged immunoglobulin heavy chain gene
[17], might be useful in the future to confirm our estimates.
These results, combined with evidence of widespread random
monoallelic expression [5], indicate that expression data from
LCLs are not well suited to detect correlations between SNPs and
gene expression. When for a given gene the expression is affected
by methylation patterns or other epigenetic meiotically stable
factors [5], the expression measurement in LCLs will not be
representative of the in vivo cell population. Strong allelic
imbalance can result from the random inactivation of the same
allele in the small number of clones that constitute the LCL,
resulting in increased false positive and false negative rates.
Consequently, we expect that the fraction of human genes affected
by monoallelic expression [5] will be highly differentially expressed
in the approximately 20% of monoclonal LCLs. In fact, any gene
expression measurement that is variable across cells in vivo can be
significantly altered by the random subsampling of a small number
of clones in a LCL. This additional measurement noise will affect
the power of genome-wide association studies, or, indeed, specific
gene studies to detect association between SNPs and expression
traits in LCLs. Consequently, we recommend, where possible, to
either screen the LCLs for monoclonality or use bulk, non cell line,
ex vivo cells when measuring gene expression [18], and in particular
when focusing on allele-specific expression [1].
Methods
Dataset
The data consisted of two sets of LCLs: 466 samples from
healthy women (British 1958 Birth Cohort, see [8]) and 708
samples from type 1 diabetic women (Juvenile Diabetes Research
Foundation/Wellcome Trust British T1D case collection), with all
samples originating from England, Scotland and Wales. In
addition, the control set consisted of 343 samples from Turkish
healthy women for which DNA was isolated from peripheral
blood. For the T1D cell lines, additional information describing
the cell line preparation was available (see Protocol S1).
X inactivation and clonality in LCL
X inactivation is a process by which, early in the female
mammals’ development, epigenetic modifications randomly inac-
tivate one of the two copies of the X chromosome to guarantee a
comparable gene dosage between male and females. Consequent-
ly, a female is a mosaic of two cell types in which either the
maternal or the paternal chromosome is inactivated. The
proportion of the most common of these two cell populations,
expressed as a percentage between 50% and 100%, is called the
level of skewing in XCI. We measured XCI using a standard
assay [7].
Mathematical model for XCI in cell lines
In the presence of a bottleneck, we modelled the skew in the cell
line samples (denoted by the random variable Y*) as follows:
Y *Binomial p~X ,nð Þ
where n,Poisson(m) is the bottleneck size (we assume a Poisson
random variable with mean m that we want to estimate) and X is a
random variable describing the skew in the population estimated
from the Turkish control samples (using peripheral blood and not
cell lines). We also investigated a version of this scenario where the
bottleneck always involves a single clone. The XCI variable Y,
measured between 0.5 and 1, is obtained by adding an error term e:
Y^~Y ze
Y~max Y^ ,1{Y^
 
e is a truncated Gaussian random variable with mean 0 and standard
deviation s=0.03,0.05,0.1. The truncation ensures that YˆM{0,1}.
Likelihood estimation
The fraction of LCLs undergoing a bottleneck is denoted by f
and the number of cells n in the bottleneck is Poisson(m). Parameters
are estimated using a maximum likelihood approach, maximizing
the likelihood over a two dimensional grid of values for (f,m). We
summarized the XCI data using ten uniformly spaced bins Bið Þ101 .
The distribution of the measured XCI, denoted by Y, is therefore
multinomial with parameters (p1,…,p10) where pi= P(YMBi).
For given values of the parameters (f,m) the probabilities pi are
estimated as follows:
pi~ 1{fð ÞP X[Bið Þzf
X
j
P n~j mjð ÞP Y[Bi n~jjð Þ
where X designates the XCI randomly sampled from the control
Turkish population.
P(YMBi|n= j) is the probability that the measured skew Y is
located in the bin Bi conditionally on a bottleneck of size j:
P Y[Bi n~jjð Þ~
Xj
k~0
P Binomial p~X ,jð Þ~k½ P k=jze[Bi½ 
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